RESEARCH-USE BIOSIMILAR ANTIBODY
Ragifilimab
Monoclonal antibody · IgG1
Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting the glucocorticoid-induced TNFR-related protein (GITR). Ragifilimab binds to and activates GITR on T cells, which stimulates the immune system to enhance its anti-tumor activity. Ragifilimab can be used for advanced or metastatic solid tumors research.
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting the glucocorticoid-induced TNFR-related protein (GITR). Ragifilimab binds to and activates GITR on T cells, which stimulates the immune system to enhance its anti-tumor activity. Ragifilimab can be used for advanced or metastatic solid tumors research.
Ragifilimab is a recombinant research-use antibody directed against TNFRSF18.